Blood tests for thrombophilia are specialised investigations used to determine if a person has a biological tendency to form blood clots more easily than usual. These tests are grouped into a “thrombophilia screen” which examines both genetic markers and the levels of specific proteins that regulate the body’s clotting mechanism. Because many factors including recent illness, pregnancy, and certain medications can influence the results, these tests must be performed under specific clinical conditions to ensure accuracy. In the UK, healthcare professionals use these results to assess the risk of future clots and to tailor long-term management plans for patients who have experienced unexplained thrombosis.
What We’ll Discuss in This Article
- The components of a standard thrombophilia screen
- Testing for inherited genetic mutations like Factor V Leiden
- Measuring natural anticoagulant proteins in the blood
- Identifying acquired conditions such as antiphospholipid syndrome
- The impact of medications and timing on test results
- Clinical criteria for undergoing thrombophilia testing in the UK
Components of a Thrombophilia Screen
A thrombophilia screen is a comprehensive set of laboratory tests that look for various factors that could contribute to an increased risk of venous thromboembolism. The screen is typically divided into two main categories: tests for inherited (genetic) traits and tests for acquired (developed) conditions. Depending on a patient’s clinical history, a doctor may order a “full screen” or target specific markers that are most relevant to the individual’s symptoms. The NHS provides information on how these blood tests are used to check for altered genes or changes in blood cells linked to thrombophilia to help manage the risk of future clots.
Testing for Inherited Mutations
Genetic testing is used to identify permanent changes in the DNA that affect the blood-clotting process. The two most common genetic tests look for the Factor V Leiden mutation and the Prothrombin gene mutation (G20210A). These tests are highly reliable because they are performed using a DNA analysis technique that is not affected by current medications or recent clotting events. Unlike protein-based tests, genetic tests only need to be performed once in a lifetime, as the results will not change over time.
Measuring Natural Anticoagulants
The body produces several proteins that act as natural “brakes” on the clotting system, and a deficiency in any of these can lead to thrombophilia. A standard screen measures the activity or levels of Antithrombin (formerly Antithrombin III), Protein C, and Protein S. If these proteins are below the normal range, the blood’s ability to stop a clot from growing is impaired. However, the levels of these proteins can be temporarily lowered by an active blood clot or by liver disease, so doctors often wait until a patient is in a “steady state” before interpreting these specific results.
Identifying Acquired Thrombophilia
Acquired thrombophilia is most caused by antiphospholipid syndrome (APS), where the immune system produces antibodies that interfere with blood flow. The blood tests for this condition look for three specific markers: lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein-I antibodies. Because these antibodies can appear temporarily after an infection, UK medical standards require the tests to be positive on two separate occasions, at least 12 weeks apart, to confirm a diagnosis of APS.
Timing and Medication Interference
The accuracy of a thrombophilia screen is highly dependent on when the blood is drawn and what medications the patient is currently taking. Clotting-based assays, such as those for Protein C, Protein S, and the lupus anticoagulant, can be severely affected by blood-thinning medications like warfarin, heparin, and direct oral anticoagulants. NICE guidelines advise that thrombophilia testing should generally be delayed until at least several weeks after a patient has finished their initial course of anticoagulation to ensure the results accurately reflect their baseline state. Testing during an acute illness or pregnancy can also lead to misleadingly low levels of certain proteins.
Clinical Indications for Testing
In the UK, thrombophilia testing is not recommended for everyone who has had a blood clot, as the results do not always change how a patient is treated. Testing is most often considered for individuals who have had a clot without an obvious cause, those who have experienced clots at a young age, or women who have had specific pregnancy complications. For many patients, a thorough medical and family history provides enough information to guide treatment without the need for complex laboratory screening. A specialist haematologist usually reviews the clinical details before authorising a full thrombophilia screen.
Conclusion
Blood tests for thrombophilia are a critical diagnostic tool for identifying underlying risks in patients with unexplained blood clots. By examining both genetic markers and regulatory proteins, healthcare providers can build a detailed profile of a person’s blood health. Success in diagnosis relies on careful timing and the avoidance of interfering medications during the testing process. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
How many tubes of blood are needed for the test?
A full thrombophilia screen usually requires several tubes of blood, often including four or five citrate tubes and a separate DNA sample tube, to cover all the necessary assays.
Can I be tested while I am taking aspirin?
Low-dose aspirin does not typically interfere with most thrombophilia tests, but you should always inform the medical team of all medications you are taking.
What if my results come back as “borderline”?
Borderline results for protein levels are common and usually require a repeat test after a few weeks to determine if the levels are persistently low or were just temporarily affected.
Do I need to see a specialist to get these tests?
While a GP can initiate the process, the interpretation of a thrombophilia screen is complex and is usually handled by a consultant haematologist in a hospital setting.
Is there a specific test for “sticky blood”?
“Sticky blood” is a common term for antiphospholipid syndrome, which is checked using the lupus anticoagulant and associated antibody tests mentioned above.
How long does it take for all the results to return?
While standard clotting tests may be ready in a few days, genetic and specialist antibody tests can take two to three weeks to be fully processed and reported.
Authority Snapshot (E-E-A-T)
This article provides information regarding the blood tests used to diagnose thrombophilia within the UK health system. The content is reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine and clinical laboratory interpretation. All information is strictly aligned with the current diagnostic pathways and safety standards provided by the NHS and NICE.
